Influenza

Survey shows demand high for needle-free, intranasal flu vaccine

Published in Vaccine Weekly, November 13th, 2002

According to a survey conducted by SG Cowen, there is strong demand among doctors for FluMist, a flu vaccine that is administered through the nose rather than by a shot in the arm.

The survey also concludes that patients would overwhelmingly prefer the intranasal vaccine.

Confirming that patients don't like shots, the survey found that 78% of patients would prefer an intranasal vaccine versus an intramuscular vaccine, and that physicians would use FluMist in over 50% of flu vaccinations.

Additional FluMist survey findings include:

90% of physicians would prescribe a live attenuated intranasal vaccine instead of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-11-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry